◆ 会议时间：2025年9月10-13日
◆ 会议地点：巴西 圣保罗

◆ 会议简介：

2025年国际头痛大会(IHC2025)将于2025年9月10-13日在巴西圣保罗举行，本次会议由国际头痛学会(IHS)组织。国际头痛大会(IHC)每两年举行一次。IHC将为与会者提供头痛和偏头痛领域的最新治疗、发展和研究成果，大会致力于加强教育，提高认识，以改善全世界头痛疾病患者的生活。大会组委会邀请前来您分享您的知识，并了解有关头痛治疗的最新进展。

国际头痛学会（IHS）成立于1981年，是世界领先的致力于为遭受头痛困扰的人们提供专业的服务会员制组织。作为一个慈善机构，IHS的目的是宣推进头疼科学、教育和管理的发展，促进全世界对头痛的认识。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）

International Headache Congress (IHC) 2025

Dates: 10-13 September 2025
Venue: Sao Paulo, Brazil

Orgznized by: International Headache Society

The International Headache Congress (IHC) is held every second year. The venue is selected by the IHS Board of Trustees in consultation with a Professional Congress Organiser. As an international society, the aim is to hold congresses worldwide, taking into consideration delegate and sponsor appeal.

摘要征文投稿：

• Submissions accepted from: 18 November 2024
• Submission deadline: 5 May 2025 at 23:59 (Brasilia time)
• Abstracts Review: May 2025
• Late-breaking abstract submission opens – 31 May 2025
• Late-breaking abstract submission closes – 15 June 2025

点此提交摘要>>>Submit Abstract>>>

ABSTRACT TOPICS

Abstracts are accepted under the following topics.

1. Access to Headache Care in low and middle-income countries
2. AI, Data Science, and Big Data
3. Cluster Headache and Other Trigeminal Autonomic Cephalalgias
4. Comorbidity of Primary Headaches
5. Genetics and Biomarkers of Headache Disorders
6. Global Burden of Disease
7. Headache Awareness and Advocacy
8. Headache Classification
9. Headache Disorders in Children and Adolescents
10. Headache Education for Clinicians and Patients
11. Headache Epidemiology, Outcomes and Burden
12. Headache and Gender
13. Headache in History and the Arts
14. Headache Pathophysiology – Basic Science
15. Headache Pathophysiology – Imaging and Neurophysiology
16. Holistic Approach for Headache
17. Migraine Acute Therapy
18. Migraine Preventive Therapy
19. Neuromodulation for Headache
20. Other Primary Headache Disorders
21. Other Secondary Headache Disorders
22. Post-Traumatic Headache
23. Psychological and Behavioural Factors and Management
24. Tension-Type Headache
25. Temporomandibular Disorders
26. Trigeminal Neuralgia and Other Cranial Neuropathies
27. Wearable Technologies for Headache
28. Other

GENERAL

1. Abstracts can only be submitted online via the abstract submission portal that can be found in the section “ABSTRACTS” on the official Congress website.
2. Abstracts must be submitted in English.
3. There is no limit of submissions per author. There is no limit of authors per submission. Please enter the authors in the desired order.

DEFINITIONS

• Submitting author: person who submits the abstract.
• Presenting author: person who will physically present the abstract at the Congress and who is marked as the presenter in the programme

PUBLICATION AND EMBARGO

All abstracts accepted for IHC 2025 will be published in the following places:

• Cephalalgia Journal – September 2025
• IHC 2025 Congress app

All abstracts accepted for IHC 2025 will be under embargo until 09:00 (Brasilia time) on the morning of Wednesday 10 September 2025

RULES

Failure to observe these guidelines may result in disqualification.

1. An abstract can be submitted to the IHC 2025 if it has been presented or published at a national meeting, however this must be stated during submission. Submissions presented at international Congresses previously will not be accepted. In addition to this, the abstract results must not have been previously published within a journal.

2. The correct topic must be selected to ensure correct scoring. The content of the abstract must be topic related. The Scientific Committee reserve the right to re-categorise an abstract.

3. Abstracts must contain data and meet international ethical standards.

4. Abbreviations should be defined.

5. Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.

6. An abstract cannot be accepted if the conflict of interest disclosure has not been completed on the submission form. If the presenter or one of the co-authors has a conflict of interest, this must be clearly stated. Accurate disclosures are the authors' responsibility.

7. The abstract cannot contain more than 2,500 characters (approx.700 words) – blank spaces, punctuation, author names, affiliations and titles are included in the character count. The title must contain a minimum of 20 characters and maximum of 300 characters.

8. The abstract must be structured into the following sections: Objective; Methods; Results; Conclusion

9. One table can be included, with the following restrictions:

Max number of columns: 10
Max number of rows: 10

10. Please note that tables may significantly reduce the number of available characters.

11. One figure can be included – this will not be included in the word count.

12. If you have successfully submitted your abstract, you will receive a confirmation number. If no confirmation number is received, the abstract cannot be considered as successfully submitted and accepted.

13. Abstracts fulfilling all criteria can be saved in “FINAL SUBMISSION” status. Only abstracts in “FINAL SUBMISSION” status will be considered as successfully submitted and accepted.

14. If you leave the system without saving the abstract all data is lost. The submitted/draft abstracts cannot be edited after the submission deadline (Monday, 05 May 2025, 23:59 Brasilia time).

15. Please ensure that your abstract does not contain spelling, grammatical or scientific errors. No corrections are possible after the submission deadline. The abstract will be reproduced exactly as submitted. No proof reading will be completed.

16. If you need to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to camila.mazotti@ccmgroup.com.br - no later than 23 May 2025.

IHC2025 注册费：

IHS = International Headache Society

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。